Skinvisible, Inc. (SKVI) is “One to Watch”
Patented technology enhances how topical and transdermal drugs and skin care products are delivered Polymer delivery vehicle can be tailored to almost any type of molecule including the medicinal components of hemp and marijuana 14 patents granted in the U.S. and internationally $65 billion market in dermatology, pharmaceutical and other healthcare industries offers strong growth opportunity Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible’s formulations to sell their…